Dai, B.* ; Grau, M.* ; Juilland, M.* ; Klener, P.* ; Höring, E.* ; Molinsky, J.* ; Schimmack, G. ; Aukema, S.M.* ; Hoster, E.* ; Vogt, N.* ; Staiger, A.M.* ; Erdmann, T.* ; Xu, W.* ; Erdmann, K.* ; Dzyuba, N.* ; Madle, H.* ; Berdel, W.E.* ; Trneny, M.* ; Dreyling, M.* ; Jöhrens, K.* ; Lenz, P.* ; Rosenwald, A.* ; Siebert, R.* ; Tzankov, A.* ; Klapper, W.* ; Anagnostopoulos, I.* ; Krappmann, D. ; Ott, G.* ; Thome, M.* ; Lenz, G.*
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
Blood 129, 333-346 (2017)
Mantle cell lymphoma (MCL) is a mature B-cell lymphoma characterized by poor clinical outcome. Recent studies revealed the importance of B-cell receptor (BCR) signaling in maintaining MCL survival. However, it remains unclear which role MALT1, an essential component of the CARD11-BCL10-MALT1 complex that links BCR signaling to the NF-κB pathway, plays in the biology of MCL. Here we show that a subset of MCLs is addicted to MALT1, as its inhibition by either RNA or pharmacologic interference induced cytotoxicity both in vitro and in vivo. Gene expression profiling following MALT1 inhibition demonstrated that MALT1 controls an MYC-driven gene expression network predominantly through increasing MYC protein stability. Thus, our analyses identify a previously unappreciated regulatory mechanism of MYC expression. Investigating primary mouse splenocytes, we could demonstrate that MALT1-induced MYC regulation is not restricted to MCL, but represents a common mechanism. MYC itself is pivotal for MCL survival because its downregulation and pharmacologic inhibition induced cytotoxicity in all MCL models. Collectively, these results provide a strong mechanistic rationale to investigate the therapeutic efficacy of targeting the MALT1-MYC axis in MCL patients.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Nf-kappa-b; Paracaspase Malt1; T-cells; Activation; Cleavage; Lubac; Pathogenesis; Survival; Proliferation; Inactivation
Keywords plus
Sprache
Veröffentlichungsjahr
2017
Prepublished im Jahr
HGF-Berichtsjahr
2017
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 129,
Heft: 3,
Seiten: 333-346
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Society of Hematology
Verlagsort
Washington
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Signaling and Translation (SAT)
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-509800-002
Förderungen
Copyright
Erfassungsdatum
2017-03-17